Sales Of Ngs Data Analysis Solutions Worldwide Are Forecast To Reach Nearly US$ 280 Mn In Revenues By 2026-End

Healthcare

According to a recently composed report of Fact.MR, the global NGS data analysis market will reflect an impressive expansion over the period, 2017 to 2026. Sales of NGS data analysis solutions worldwide are forecast to reach nearly US$ 280 Mn in revenues by 2026-end.

Request Sample

Market Taxonomy

Region
  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA
Service Type
  • Whole-Genome Sequencing
  • Exome Sequencing
  • Targeted Resequencing
  • De Novo Sequencing
  • RNA Sequencing
  • ChIP Sequencing
  • Methyl Sequencing
  • Other Services
End User
  • Hospitals
  • Academic Research Institutes
  • Biotechnology/Pharmaceutical Companies
  • Contract Research Organization
  • Other End Users
Technique
  • Sequencing by Synthesis (SBS) Technology
  • Real-Time (SMRT) Technology
  • Ion semiconductor sequencing Technology
  • Others

Competition Tracking

Major companies providing the NGS data analysis solutions have been undertaking strategic collaborations & partnerships, in a bid to increase their existing product portfolios, meanwhile maintaining a competitive edge in the market.

These collaborations & partnerships are primarily focused at developing feasible infrastructure solutions for enabling researchers in performing a population-scale genomic analysis.

Key market participants supporting growth of the global NGS data analysis market include

  • ABM Inc.
  • Agilent Technologies
  • Biomatters Ltd
  • DNAnexus
  • Dovetail Genomics
  • LLC
  • Edge Biosystems
  • Genestack
  • Illumina
  • Roche.

Leave a Reply

Related Posts